4 completed. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow AMIpharm Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Efficacy and Safety of AYP-101 for the Reduction of Submental Fat in Chin Area Polyene Phosphatidylcholine, Matching placebo of AYP-101 - Healthy | Phase 3 | Completed | AMIpharm Co., Ltd. | 252 | 2024-03-26 | 2026-01-22 |
| Evaluate Pharmacokinetic/Pharmacodynamic and Safety/Tolerability of AYP-101 in Healthy Subjects Polyene Phosphatidylcholine - Healthy Subjects, Submental Fat | Phase 1 | Completed | AMIpharm Co., Ltd. | 26 | 2022-08-10 | 2026-01-22 |
| Determine the Dosing Interval and Optimal Dose of AYP-101 for the Reduction of Submental Fat in Chin Area Polyene Phosphatidylcholine, Placebo - Moderate or Severe Submental Fullness | Phase 2 | Completed | AMIpharm Co., Ltd. | 96 | 2022-03-02 | 2023-08-15 |
| Evaluate the Efficacy and Safety of Polyene Phosphatidylcholine Injection (AYP-101) for the Reduction of Submental Fat Polyene phosphatidylcholine injection, Placebo - Moderate or Severe Submental Fullness | Phase 2 | Completed | AMIpharm Co., Ltd. | 143 | 2019-07-01 | 2023-08-15 |
polyene phosphatidylcholine (4)
South Korea (4)
Beomjoon Kim, MD (1) · Dae Hyeon Lew, MD,PhD (1) · Jae Yong Chung, M.D.,Ph.D (1)